Multiple Sclerosis Walking Scale (MSWS-12): exactly what clinical benefits do prolonged-release fampridine responders actually get?

Research output: Contribution to journal › Article › peer-review

Cite this

@article{fcb62875f3e148eaa2a21b926b95e505,

title = "Multiple Sclerosis Walking Scale (MSWS-12): exactly what clinical benefits do prolonged-release fampridine responders actually get?",

author = "J Hobart",

year = "2011",

language = "English",

volume = "17",

pages = "S319--S320",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "0",

}